Israel Corporation Ltd

Israel Corporation Ltd, through its investee companies, operates in the specialty minerals and refining businesses in Asia, Europe, South America, North America, and internationally. The company offers bromine and bromine-based compounds; salts, magnesium chloride, magnesia-based products, phosphorus-based flame retardants, and functional fluids; potash and electricity; phosphate-based specialty products; and controlled release fertilizers, water soluble fertilizers, liquid fertilizers and straights, FertilizerspluS range products, soil and foliar micronutrients, secondary nutrients, biostimulants, soil conditioners, seed treatment products, and adjuvants. It also produces fuel products; raw materials for the petrochemical industry; and materials for the plastics industry, as well as provides power and water services to various industries in Haifa. The company is based in Tel Aviv, Israel.

Israel Corporation Ltd trades as IRLCF on OTC. The company is classified in Basic Materials / Chemicals - Specialty and reports in USD.

The current profile places the business in Chemicals - Specialty. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $7.74B of revenue and $94.17M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Israel Corporation Ltd can be compared against peers such as AlzChem Group AG, Borregaard ASA, Dowa Holdings Co., Ltd., Kaneka Corporation, Lanxess AG, Lanxess AG.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $1.82B, beta of 0.16, and return on equity of +3.1%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

IRLCF currently shows total debt of $3.44B and beta of 0.16. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.israelcorp.com

For Israeli stocks, verify official filings and local reports before publishing the thesis.